Will novel oral formulations change the management of inflammatory bowel disease?
about
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.JAK inhibition in inflammatory bowel disease.The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.Next generation of small molecules in inflammatory bowel disease.Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds
P2860
Will novel oral formulations change the management of inflammatory bowel disease?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Will novel oral formulations change the management of inflammatory bowel disease?
@en
type
label
Will novel oral formulations change the management of inflammatory bowel disease?
@en
prefLabel
Will novel oral formulations change the management of inflammatory bowel disease?
@en
P2860
P50
P1476
Will novel oral formulations change the management of inflammatory bowel disease?
@en
P2093
Mark Ainsworth
Mehmet Coskun
P2860
P304
P356
10.1517/13543784.2016.1165204
P407
P577
2016-03-11T00:00:00Z